BCL2 and breast carcinoma: The capability of the nanoparticles to induce apoptosis in MCF-7 breast carcinoma cells was investigated via intracellular ROS analysis, Bax/Bcl-2 analysis, antioxidant enzyme levels, and Hoechst staining.